STOCK TITAN

[Form 4] HealthEquity, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Boise Cascade Company (NYSE: BCC) filed a Form 8-K on 31 Jul 2025 under Item 7.01. The board of directors declared a $0.22 per-share quarterly cash dividend on its common stock. The dividend is payable 17 Sep 2025 to shareholders of record at the close of business on 2 Sep 2025. The disclosure is furnished, not filed, so it will not be incorporated by reference into other SEC filings. No additional financial results, guidance, or material transactions were reported.

La Boise Cascade Company (NYSE: BCC) ha presentato un modulo 8-K il 31 luglio 2025 ai sensi del punto 7.01. Il consiglio di amministrazione ha dichiarato un dividendo trimestrale in contanti di 0,22 USD per azione sulle azioni ordinarie. Il dividendo sarà pagabile il 17 settembre 2025 agli azionisti registrati alla chiusura delle attività del 2 settembre 2025. La comunicazione è fornita, non depositata, pertanto non sarà incorporata per riferimento in altri documenti SEC. Non sono stati riportati ulteriori risultati finanziari, previsioni o operazioni rilevanti.

Boise Cascade Company (NYSE: BCC) presentó un Formulario 8-K el 31 de julio de 2025 bajo el punto 7.01. La junta directiva declaró un dividendo trimestral en efectivo de 0,22 USD por acción sobre sus acciones comunes. El dividendo se pagará el 17 de septiembre de 2025 a los accionistas registrados al cierre del negocio el 2 de septiembre de 2025. La divulgación se proporciona, no se presenta oficialmente, por lo que no se incorporará por referencia en otros documentos de la SEC. No se reportaron resultados financieros adicionales, previsiones ni transacciones materiales.

Boise Cascade Company(NYSE: BCC)는 2025년 7월 31일 8-K 양식을 항목 7.01에 따라 제출했습니다. 이사회는 보통주에 대해 주당 0.22달러 분기 현금 배당금을 선언했습니다. 배당금은 2025년 9월 17일에, 2025년 9월 2일 영업 종료 시점의 주주 명부에 등재된 주주에게 지급됩니다. 이 공시는 제출된 것이 아니라 제공된 것이므로 다른 SEC 제출 서류에 참조로 포함되지 않습니다. 추가 재무 결과, 전망 또는 중요한 거래는 보고되지 않았습니다.

Boise Cascade Company (NYSE : BCC) a déposé un formulaire 8-K le 31 juillet 2025 conformément à l'article 7.01. Le conseil d'administration a déclaré un dividende trimestriel en espèces de 0,22 $ par action sur ses actions ordinaires. Le dividende sera payable le 17 septembre 2025 aux actionnaires inscrits à la clôture des opérations le 2 septembre 2025. Cette divulgation est fournie, non déposée, elle ne sera donc pas intégrée par référence dans d'autres documents déposés auprès de la SEC. Aucun résultat financier supplémentaire, prévision ou transaction importante n'a été rapporté.

Die Boise Cascade Company (NYSE: BCC) reichte am 31. Juli 2025 ein Formular 8-K unter Punkt 7.01 ein. Der Vorstand erklärte eine vierteljährliche Bardividende von 0,22 USD pro Aktie auf die Stammaktien. Die Dividende wird am 17. September 2025 an die Aktionäre ausgezahlt, die am Geschäftsschluss des 2. September 2025 im Aktienregister eingetragen sind. Die Offenlegung wird bereitgestellt, nicht eingereicht, daher wird sie nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Es wurden keine zusätzlichen Finanzergebnisse, Prognosen oder wesentlichen Transaktionen gemeldet.

Positive
  • $0.22 quarterly cash dividend affirms ongoing shareholder return policy.
Negative
  • None.

Insights

TL;DR – Routine dividend declaration; mildly supportive for income investors, no broader strategic implications.

The 8-K simply confirms continuation of Boise Cascade’s quarterly dividend at $0.22 per share. While cash returns strengthen shareholder yield and signal confidence in cash flow, the payout size is immaterial to valuation without context on earnings coverage. No operations, guidance, or balance-sheet changes were revealed, so the filing lacks market-moving information. Impact: neutral, with a slight positive tilt for dividend-focused holders.

La Boise Cascade Company (NYSE: BCC) ha presentato un modulo 8-K il 31 luglio 2025 ai sensi del punto 7.01. Il consiglio di amministrazione ha dichiarato un dividendo trimestrale in contanti di 0,22 USD per azione sulle azioni ordinarie. Il dividendo sarà pagabile il 17 settembre 2025 agli azionisti registrati alla chiusura delle attività del 2 settembre 2025. La comunicazione è fornita, non depositata, pertanto non sarà incorporata per riferimento in altri documenti SEC. Non sono stati riportati ulteriori risultati finanziari, previsioni o operazioni rilevanti.

Boise Cascade Company (NYSE: BCC) presentó un Formulario 8-K el 31 de julio de 2025 bajo el punto 7.01. La junta directiva declaró un dividendo trimestral en efectivo de 0,22 USD por acción sobre sus acciones comunes. El dividendo se pagará el 17 de septiembre de 2025 a los accionistas registrados al cierre del negocio el 2 de septiembre de 2025. La divulgación se proporciona, no se presenta oficialmente, por lo que no se incorporará por referencia en otros documentos de la SEC. No se reportaron resultados financieros adicionales, previsiones ni transacciones materiales.

Boise Cascade Company(NYSE: BCC)는 2025년 7월 31일 8-K 양식을 항목 7.01에 따라 제출했습니다. 이사회는 보통주에 대해 주당 0.22달러 분기 현금 배당금을 선언했습니다. 배당금은 2025년 9월 17일에, 2025년 9월 2일 영업 종료 시점의 주주 명부에 등재된 주주에게 지급됩니다. 이 공시는 제출된 것이 아니라 제공된 것이므로 다른 SEC 제출 서류에 참조로 포함되지 않습니다. 추가 재무 결과, 전망 또는 중요한 거래는 보고되지 않았습니다.

Boise Cascade Company (NYSE : BCC) a déposé un formulaire 8-K le 31 juillet 2025 conformément à l'article 7.01. Le conseil d'administration a déclaré un dividende trimestriel en espèces de 0,22 $ par action sur ses actions ordinaires. Le dividende sera payable le 17 septembre 2025 aux actionnaires inscrits à la clôture des opérations le 2 septembre 2025. Cette divulgation est fournie, non déposée, elle ne sera donc pas intégrée par référence dans d'autres documents déposés auprès de la SEC. Aucun résultat financier supplémentaire, prévision ou transaction importante n'a été rapporté.

Die Boise Cascade Company (NYSE: BCC) reichte am 31. Juli 2025 ein Formular 8-K unter Punkt 7.01 ein. Der Vorstand erklärte eine vierteljährliche Bardividende von 0,22 USD pro Aktie auf die Stammaktien. Die Dividende wird am 17. September 2025 an die Aktionäre ausgezahlt, die am Geschäftsschluss des 2. September 2025 im Aktienregister eingetragen sind. Die Offenlegung wird bereitgestellt, nicht eingereicht, daher wird sie nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Es wurden keine zusätzlichen Finanzergebnisse, Prognosen oder wesentlichen Transaktionen gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neeleman Stephen

(Last) (First) (Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100

(Street)
DRAPER UT 84020

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
FOUNDER AND VICE CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 112,593 D
Common Stock 07/28/2025 G 3,000 D $0 550,235 I See footnote(1)
Common Stock 203,000 I See footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $41.28 (3) 03/27/2027 Common Stock 19,897 19,897 D
Stock Options (right to buy) $61.72 (3) 03/27/2028 Common Stock 14,228 14,228 D
Stock Options (right to buy) $73.61 (3) 03/26/2029 Common Stock 15,337 15,337 D
Explanation of Responses:
1. Shares held of record by the Stephen and Christine Neeleman Trust.
2. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
3. The option is immediately exercisable.
/s/ Stephen Neeleman 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What dividend did Boise Cascade (BCC) declare on July 31, 2025?

The board declared a $0.22 per-share quarterly cash dividend.

When is the record date for BCC’s new dividend?

Shareholders must be on record by September 2, 2025 to receive the dividend.

When will Boise Cascade pay the $0.22 dividend?

Payment is scheduled for September 17, 2025.

Under which 8-K item is the dividend disclosure provided?

The information is furnished under Item 7.01 – Regulation FD Disclosure.

Is the dividend information considered “filed” with the SEC?

No. It is furnished, not filed, and is not incorporated by reference into other filings.

Did the 8-K announce any other material events for BCC?

No additional financial results or transactions were disclosed beyond the dividend.
Healthequity Inc

NASDAQ:HQY

HQY Rankings

HQY Latest News

HQY Latest SEC Filings

HQY Stock Data

8.54B
84.52M
2.14%
106.13%
4.97%
Health Information Services
Services-business Services, Nec
Link
United States
DRAPER